11.04.2016 07:02:00

Evolva to Co-Develop Next-Generation Materials with US Navy

Evolva (SIX: EVE) announced that it has completed a Limited Purpose Cooperative Research and Development Agreement (CRADA) to support the joint development of novel advanced materials with the US Navy. The focus of the efforts supported by this CRADA relate to the development, validation and potential commercialisation of new lightweight, fire-resistant composite materials to save lives and reduce harm from fire.

Applications of these advanced materials include aircraft, waterborne craft, fabrics, armoured vehicles, and construction materials. These next-generation composite materials are based on a molecule that can be manufactured on an industrial scale using advanced biotechnology and fermentation, and then polymerised and shaped/moulded using standard fabrication techniques.

If successful, this project would create for the US Navy novel composite materials that are fire resistant, stronger and lighter than aluminium, and capable of withstanding high temperatures. These materials would also be more sustainably sourced, less expensive, and offer a number of other advantages over existing composites.

"This agreement highlights and validates the versatility of our product innovation platform and depth of our plant science expertise,” said Evolva CEO Neil Goldsmith. "This CRADA also illustrates just how far and wide Evolva is making inroads across multiple industries with its building-with-biology platform.”

- ends -

About Evolva

Evolva is a pioneer and global leader in sustainable, fermentation-based approaches to ingredients for health, wellness and nutrition. Evolva’s products include stevia, resveratrol, vanillin, nootkatone and saffron. As well as developing its own proprietary ingredients, Evolva also deploys its technology for partners, providing them with a competitive edge and sharing in the returns they make. For more information see www.evolva.com. Questions about our fermentation approach? Have a look at our video.

This press release contains specific forward-looking statements, e.g. statements including terms like believe, assume, expect or similar expressions. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors which may result in a substantial divergence between the actual results, financial situation, development or performance of the company and those explicitly or implicitly presumed in these statements. Against the background of these uncertainties readers should not place undue reliance on forward-looking statements. The company assumes no responsibility to update forward-looking statements or to adapt them to future events or developments.

Nachrichten zu Evolva AGmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Evolva AGmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!